Opportunities for Collaboration and Innovation with Swarm Learning
- Maria Palombini, Director, Healthcare and Life Sciences Practice, IEEE SA
- Prof. Dr. Joachim L. Schultze, Director Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. (DZNE); Director, Genomics & Immunoregulation, LIMES-Institute, University of Bonn Germany
- Krishnaprasad Shastry, Director, Distinguished Technologist, Hewlett Packard Enterprise (HPE)
- Vikram Shetty, Medical Director, Singapore and Asia Area Lung Cancer Lead, AstraZeneca
Key learnings will include:
- Understanding the differences between federated machine vs swarm learning
- The technical, policy and application barriers when it relates to transferring significant amounts of data
- The steps and frameworks needed to drive wider understanding and adoption of the technology in clinical R&D
- The pharma perspective: where does Swarm AI offer new solutions yet to be introduced to the drug development process
